With Cardiovascular Disease Becoming The Most Common Cause Of Death In People With Diabetes, Interest In The Assessment And Treatment Of Heart Disease In These Patients Has Been Reawakened
Posted on: Tuesday, 20 November 2007, 09:00 CST
Research and Markets (http://www.researchandmarkets.com/reports/c74914) has announced the addition of "Diabetic Cardiology" to their offering
With cardiovascular disease becoming the most common cause of death in people with diabetes, interest in the assessment and treatment of heart disease in these patients has been reawakened. This book examines developing topics from a largely cardiological perspective, covering both pharmacological and non-pharmacological interventions.
The DIGAMI study on the use of intravenous insulin infusion at the time of myocardial infarction (MI) has stimulated a large number of discussion papers on the best treatment of MI in the diabetic patient. The UKPDS has shown that treatment of Type 2 diabetes does not reduce cardiovascular end-points significantly, but that aggressive treatment of blood pressure can do so. In addition, sub-group analysis from several large cardiovascular trials has shown that treatment with statins, anti-platelet therapy, ACE inhibitors and other drugs will also reduce cardiovascular events in people with diabetes.
About the Author
Miles Fisher
Consultant Physician, Glasgow Royal Infirmary
John McMurray
Professor of Medical Cardiology, British Heart Foundation Cardiovascular Research Centre, University of Glasgow and Honorary Consultant Cardiologist, Western Infirmary, Glasgow
Topics Covered:
1. Epidemiology of vascular disease in diabetes (Susan Laing).
2. Pathogenesis of atherosclerosis and vascular disease in type 2 diabetes (Naveed Sattar and Alistair Cormack).
3. Coronary heart disease and diabetes (Colin Berry, Miles Fisher and John McMurray).
4. Diabetes and acute coronary syndromes (Colin Berry, Miles Fisher and John McMurray).
5. Diabetes, left ventricular systolic dysfunction and chronic heart failure (Michael R MacDonald, Mark C Petrie, Nathaniel M Hawkins and John J V McMurray).
6. Diabetes and hypertension (Gordon T McInnes).
7. Diabetes and strokes/transient ischaemic attacks (Christopher S Gray and Janice E O'Connell).
8. Diabetes and peripheral arterial disease (Iskandar Idris and Richard Donnelly).
9. Prevention of cardiovascular events in diabetic patients (Markku Laakso).
10. Prevention of diabetes as a means of preventing cardiovascular disease (Stephen J Cleland and Jonathan Shaw).
11. Diabetes for cardiologists (David MacFarlane, Colin Perry and Miles Fisher).
For more information, visit http://www.researchandmarkets.com/reports/c74914
Source: Business Wire
Related Articles
- Groundbreaking Diabetes Disease Management Program Honored With URAC National Best Practices Award
- Lipitor 80 Mg Provided Sustained Risk Reduction of Cardiovascular Events in Patients With Heart Disease During the Five-Year TNT Trial
- Randy Jackson and the American Heart Association Promote Awareness About the Connection Between Type 2 Diabetes and Cardiovascular Disease
- Leaders Call for Vital Changes to Stem Growing Public Health Epidemic of Obesity, Diabetes and Cardiovascular Disease
- The Combined Impact of Obesity, Diabetes, and Cardiovascular Disease is the World's Biggest Health Problem Today
- Diabetes Disease Management Reviewed
- American Healthways Extends Agreement With Blue Cross Blue Shield of Massachusetts; Health Plan Expands Diabetes Disease Management Program
- Optimizing Treatment of Diabetes and Cardiovascular Disease With Combined [Alpha],[Beta]-Blockade
- Obesity, Inactivity, and the Prevalence of Diabetes and Diabetes- Related Cardiovascular Comorbidities in the U.S., 2000-2002
- New Book Explains Why Exercise Is Essential to Reversing Type 2 Diabetes and Cardiovascular Disease; Photo Available
 |
 |
User Comments (0)
RSS Feeds